Cargando…

Comparison of Test Your Memory and Montreal Cognitive Assessment Measures in Parkinson's Disease

Background. MoCA is widely used in Parkinson's disease (PD) to assess cognition. The Test Your Memory (TYM) test is a cognitive screening tool that is self-administered. Objectives. We sought to determine (a) the optimal value of TYM to discriminate between PD patients with and without cognitiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henderson, Emily J., Chu, Howard, Gaunt, Daisy M., Whone, Alan L., Ben-Shlomo, Yoav, Lyell, Veronica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949348/ https://www.ncbi.nlm.nih.gov/pubmed/27478678 http://dx.doi.org/10.1155/2016/1012847

Ejemplares similares

The Association Between Frailty and Parkinson’s Disease in the ReSPOnD Trial
por: Smith, Natalie, et al.
Publicado: (2021)

The ReSPonD trial - rivastigmine to stabilise gait in Parkinson’s disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson’s disease who have fallen
por: Henderson, Emily J, et al.
Publicado: (2013)

Cholinesterase inhibitor to prevent falls in Parkinson’s disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson’s disease
por: Neumann, S., et al.
Publicado: (2021)

Validation of conversion between mini–mental state examination and montreal cognitive assessment
por: Lawton, Michael, et al.
Publicado: (2016)

Floor and ceiling effects on the Montreal Cognitive Assessment in patients with Parkinson’s disease in Brazil
por: Koshimoto, Brenda Hanae Bentes, et al.
Publicado: (2023)

Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson’s disease
por: Almeida, Kelson James, et al.
Publicado: (2019)

Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson’s Disease
por: Jeon, Junbeom, et al.
Publicado: (2022)

Using the Montreal Cognitive Assessment Scale to screen for dementia in Chinese patients with Parkinson's Disease
por: CHEN, Ling, et al.
Publicado: (2013)

Application of the Chinese Version of the Montreal Cognitive Assessment-Basic for Assessing Mild Cognitive Impairment in Parkinson’s Disease
por: Xu, Qian, et al.
Publicado: (2021)

Montreal cognitive assessment reflects cognitive reserve
por: Kang, Jae Myeong, et al.
Publicado: (2018)

The Test Your Memory for Mild Cognitive Impairment (TYM-MCI)
por: Brown, Jeremy M, et al.
Publicado: (2017)

Stimulation of the Tibial nerve Repetitively to Improve Incontinence in Parkinson’s Electronically (STRIPE trial): a randomised control trial of tibial nerve stimulation for bladder symptoms in Parkinson’s disease using a self-contained wearable device
por: Smith, Matthew D., et al.
Publicado: (2022)

The MemTrax Test Compared to the Montreal Cognitive Assessment Estimation of Mild Cognitive Impairment
por: van der Hoek, Marjanne D., et al.
Publicado: (2019)

Cognitive Performance on the Montreal Cognitive Assessment Test and Retinal Structural and Functional Measures in Glaucoma
por: Bastani Viarsagh, Solmaz, et al.
Publicado: (2022)

Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue(®) to the Montreal Cognitive Assessment
por: Rose, Amanda F, et al.
Publicado: (2021)

Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease
por: Tumas, Vitor, et al.
Publicado: (2016)

The validity of the Memory Alteration Test and the Test Your Memory test for community-based identification of amnestic mild cognitive impairment
por: Ozer, Seline, et al.
Publicado: (2016)

Needs of patients with parkinsonism and their caregivers: a protocol for the PRIME-UK cross-sectional study
por: Tenison, Emma, et al.
Publicado: (2022)

Montreal Cognitive Assessment scale in patients with Parkinson Disease with normal scores in the Mini-Mental State Examination
por: Vásquez, Krisly Arguedas, et al.
Publicado: (2019)

Longitudinal Measurement Properties of the Montreal Cognitive Assessment
por: Andersson, Björn, et al.
Publicado: (2021)

Montreal
por: Dell, Harry H.
Publicado: (1896)

Montreal
por: McGregor, James
Publicado: (1899)

Correlation of MRI findings and cognitive function in multiple sclerosis patients using montreal cognitive assessment test
por: Ashrafi, Farzad, et al.
Publicado: (2016)

The Association between Montreal Cognitive Assessment Memory Scores and Hippocampal Volume in a Neurodegenerative Disease Sample
por: Ritter, Aaron, et al.
Publicado: (2017)

Validation of the Conversion between the Mini-Mental State Examination and Montreal Cognitive assessment in Korean Patients with Parkinson’s Disease
por: Kim, Ryul, et al.
Publicado: (2018)

Comparison of Montreal cognitive assessment and Mattis dementia rating scale in the preoperative evaluation of subthalamic stimulation in Parkinson’s disease
por: Gülke, Eileen, et al.
Publicado: (2022)

Validity and diagnostics of the Italian version of the Montreal Cognitive Assessment (MoCA) in non-demented Parkinson’s disease patients
por: D’Iorio, Alfonsina, et al.
Publicado: (2023)

Routine cognitive screening in older patients admitted to acute medicine: abbreviated mental test score (AMTS) and subjective memory complaint versus Montreal Cognitive Assessment and IQCODE
por: Pendlebury, S. T., et al.
Publicado: (2015)

Testing Shortened Versions of Smell Tests to Screen for Hyposmia in Parkinson's Disease
por: Auger, Stephen D., et al.
Publicado: (2020)

Comparison of Alternate and Original Items on the Montreal Cognitive Assessment
por: Lebedeva, Elena, et al.
Publicado: (2016)

Concordance of the Montreal cognitive assessment with standard neuropsychological measures
por: Vogel, Sally J., et al.
Publicado: (2015)

The Montreal Cognitive Assessment Test: A Useful Tool in Screening of Cognitive Impairment in Patients With Systemic Lupus Erythematosus
por: Paez-Venegas, Nicolas, et al.
Publicado: (2019)

Comparing the Electronic and Standard Versions of the Montreal Cognitive Assessment in an Outpatient Memory Disorders Clinic: A Validation Study
por: Berg, Jody-Lynn, et al.
Publicado: (2018)

Montreal Cognitive Assessment of cognitive dysfunction after basal ganglia stroke
por: Ye, Baoye, et al.
Publicado: (2022)

A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia
por: Rademeyer, Mia, et al.
Publicado: (2016)

Predicting motor, cognitive & functional impairment in Parkinson's
por: Lo, Christine, et al.
Publicado: (2019)

Predictors of cognitive impairment in an early stage Parkinson’s disease cohort
por: Hu, Michele T M, et al.
Publicado: (2014)

How to apply the results of a research paper on diagnosis to your patient
por: Whiting, Penny, et al.
Publicado: (2013)

Ventral Striatal Dopamine Synthesis Capacity Predicts Financial Extravagance in Parkinson’s Disease
por: Lawrence, Andrew D., et al.
Publicado: (2013)

Quick screening of cognitive function in Indian multiple sclerosis patients using Montreal cognitive assessment test-short version
por: Kaur, Darshpreet, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_insddl6n17m75lie0hgpsh0iri